...
首页> 外文期刊>Journal of Clinical Ultrasound: JCU >Accuracy of transrectal ultrasonography in staging rectal tumors that are clinically eligible for transanal endoscopic microsurgery.
【24h】

Accuracy of transrectal ultrasonography in staging rectal tumors that are clinically eligible for transanal endoscopic microsurgery.

机译:经直肠超声检查在临床上适合经肛门内镜显微手术的直肠肿瘤分期中的准确性。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Transanal endoscopic microsurgery (TEM) is performed in patients with premalignant or selected stage T1 rectal lesions. Transrectal ultrasonography (TRUS) is an important tool in the preoperative staging of rectal lesions to determine whether lesions are suitable for TEM or not. We analyze the accuracy of TRUS in distinguishing between rectal lesions requiring TEM or more radical excision. METHODS: From 2006 to 2008 thirty-five patients were included. All patients underwent TRUS. Following TRUS and/or additional imaging, patients underwent surgery. Preoperative TRUS staging was correlated to postoperative pathology findings. RESULTS: In 30 patients TRUS was diagnostic. Postoperative pathologic findings confirmed the preoperative TRUS findings in 29 patients; in 1 patient, a T3 staged tumor was an overstaged lesion biopsied as a tubulovillous adenoma. The accuracy level in the diagnostic TRUS group was 97% (29/30). In 5 patients TRUS was nondiagnostic; in 4 of these patients MRI was performed showing no tumor invasion in all 4 patients, confirmed by pathologic findings. Correct TRUS interpretation was possible in 86% (30/35). Overall accuracy of TRUS was 83% (29/35). CONCLUSION: TRUS is accurate in distinguishing rectal lesions suitable for TEM from the lesions needing more radical surgery. If TRUS is nondiagnostic or the lesion is of high stage (>or=T2), MRI should be performed.
机译:目的:经直肠内镜显微外科手术(TEM)适用于患有癌前或T1期直肠病变的患者。经直肠超声检查(TRUS)是直肠病变术前分期以确定病变是否适合TEM的重要工具。我们分析了TRUS在区分需要TEM或更彻底切除的直肠病变中的准确性。方法:从2006年至2008年,包括35例患者。所有患者均接受了TRUS。在TRUS和/或其他影像学检查后,患者接受了手术。术前TRUS分期与术后病理结果相关。结果:在30例患者中TRUS诊断出来。术后病理结果证实了29例患者的术前TRUS发现。在1例患者中,T3期肿瘤为活检为肾小管性腺瘤的超期病灶。诊断性TRUS组的准确度为97%(29/30)。在5例患者中,TRUS无法诊断;在这4例患者中,有4例进行了MRI检查,结果显示所有4例患者均无肿瘤浸润。正确的TRUS解释可能有86%(30/35)。 TRUS的总体准确性为83%(29/35)。结论:TRUS能够准确地区分适合TEM的直肠病变和需要更彻底手术的病变。如果TRUS不能诊断或病变为晚期(>或= T2),则应进行MRI检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号